Amarin Corp Plcuk (AMRN) Invested Capital (2010 - 2026)
Amarin Corp Plcuk (AMRN) posted quarterly Invested Capital of $449.4 million for Q1 2026, down 5.12% YoY from $473.7 million in Q1 2025, and down 2.15% sequentially from $459.3 million in Q4 2025.
Amarin Corp Plcuk (AMRN) Invested Capital (2010 - 2026) Analysis & Trends
Amarin Corp Plcuk has disclosed Invested Capital across 17 years of filings, most recently posting $449.4 million for Q1 2026.
- In Q1 2026, Invested Capital fell 5.12% year-over-year to $449.4 million; the TTM figure through Mar 2026 stood at $449.4 million (down 5.12% YoY), while the FY2025 annual figure was $459.3 million, down 5.53% from the prior year.
- Invested Capital declined to $449.4 million in Q1 2026, from $459.3 million in the prior quarter.
- Over the last five years, Invested Capital for AMRN reached as high as $641.1 million in Q1 2022 and fell as low as $449.4 million in Q1 2026.
- The 5-year median for Invested Capital is $551.9 million (2024), against an average of $534.4 million.
- Annual changes were most pronounced in 2022 — Invested Capital rose 1.02% — and 2025, when it retreated 15.76%.
- A 5-year view of Invested Capital shows it stood at $595.3 million in 2022, then declined by 7.26% to $552.1 million in 2023, then retreated by 11.94% to $486.2 million in 2024, then fell by 5.53% to $459.3 million in 2025, then fell by 2.15% to $449.4 million in 2026.
- According to Business Quant data, Invested Capital over the past three periods registered $449.4 million, $459.3 million, and $458.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | 72.79 Bn |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | 98.65 Bn |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | -6.66 Bn |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | - |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | 48.32 Bn |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | 66.51 Bn |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | 45.69 Bn |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | 90.96 Bn |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | -19.00 Mn |
| 10 | Amarin Corp Plcuk | 5.17 Bn | 5.00 Bn | 17.77 Mn | 449.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 449.41 Mn |
| Dec 31, 2025 | 459.28 Mn |
| Sep 30, 2025 | 458.89 Mn |
| Jun 30, 2025 | 464.92 Mn |
| Mar 31, 2025 | 473.69 Mn |
| Dec 31, 2024 | 486.18 Mn |
| Sep 30, 2024 | 531.38 Mn |
| Jun 30, 2024 | 551.88 Mn |
| Mar 31, 2024 | 545.94 Mn |
| Dec 31, 2023 | 552.10 Mn |
| Sep 30, 2023 | 553.15 Mn |
| Jun 30, 2023 | 569.13 Mn |
| Mar 31, 2023 | 584.79 Mn |
| Dec 31, 2022 | 595.33 Mn |
| Sep 30, 2022 | 587.83 Mn |
| Jun 30, 2022 | 580.04 Mn |
| Mar 31, 2022 | 641.11 Mn |
| Dec 31, 2021 | 667.10 Mn |
| Sep 30, 2021 | 642.50 Mn |
| Jun 30, 2021 | 645.32 Mn |